Aptar Pharma to showcase an industry first12 Sep 2018
PureHale is a new portable drug delivery device designed for upper respiratory care.
Aptar Pharma will showcase an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care - at CPhI Worldwide this year in Madrid.
In addition to PureHale, Aptar Pharma will also reveal:
“Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI, and working with our customers to meet their development needs, said Guillaume Brouet, Vice President Analytical, Regulatory and Scientific Affairs at Aptar Pharma.”
Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.
Furthermore, Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:
“Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”
Julie D. Suman, President of Next Breath, a division of Aptar Pharma, Tuesday 9 October, 11:50-12:20.
Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.
“Portable care for your respiratory tract: Exploring new technology platforms”
Guenter Nadler, Director Business Development, Aptar Pharma, Tuesday 9 October, 12:30-13:00
Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally, including new respiratory technology platforms that will meet new market needs.
“Building a connected devices eco-system for digital medicines”
Sai Shankar, Director Business Development, Aptar Pharma Wednesday 10 October, 13:50-14:20.
Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimised through patient-centric design, secure data collection and management, and cross-platform interoperability.
Vetter's Skokie facility expansion nears completion
17 Apr 2019
Expansions will help meet an increase in customer projects; a second extension is in the final planning stage.Read more
Catalent to acquire gene therapy leader Paragon Bioservices
16 Apr 2019
Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare.Read more
Colorcon expands functional film coatings through the CR Alliance with DuPont
15 Apr 2019
The Aquacoat product line provides modified release drug profiles with the added benefit of global regulatory acceptance.Read more
Hovione Technology acquires global rights to new pulmonary inhaler device
15 Apr 2019
The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.Read more
Exploristics surges ahead with £1m investment
15 Apr 2019
The loan will be used to develop KERUS Cloud - currently the only software that can simulate trials with multiple correlated outcomes - by integrating it into an intelligent software ecosystem.Read more
Catalent celebrates opening of second Shanghai facility
14 Apr 2019
Catalent’s two Shanghai locations will provide sponsors with an optimized supply solution for studies being undertaken in China, the Asia-Pacific region and globally.Read more
Global collaboration to innovate more natural and additive-free nutraceuticals
12 Apr 2019
Initiative will enable Sirio Pharma to keep abreast of regional trends, new ingredients, dosage forms and claims to provide customers unique product ideas for line extensions.Read more
Isotype-specific secondary antibodies for improved signal detection
10 Apr 2019
Offers an alternative to cross-adsorbed secondary antibodies when absolute specificity is required.Read more
Sterling Pharma to acquire CiVentiChem in the US
9 Apr 2019
The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply.Read more
New China-based biotechs fueling growth in manufacturing across China
9 Apr 2019
New guidelines will see poorer quality manufacturers drop out of the market.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation